[Education of patients treated with a continuous epoprostenol infusion for pulmonary hypertension].
Marlier
Delphine
D
Hôpital général juif, Montréal, Québec, Canada.
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D002405:Catheterization, Central Venous; D003479:Curriculum; D011464:Epoprostenol / Q000009:adverse effects / Q000627:therapeutic use*; D006769:Hospitals, General; D006801:Humans; D006976:Hypertension, Pulmonary / Q000145:classification / Q000188:drug therapy* / Q000453:epidemiology / Q000451:nursing; D015994:Incidence; D007262:Infusions, Intravenous; D010353:Patient Education as Topic / Q000458:organization & administration*; D010358:Patient Participation / Q000379:methods / Q000523:psychology; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D011792:Quebec; D012720:Severity of Illness Index
D000959:Antihypertensive Agents; D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol